Developing story β details emerging. Check the source link for the latest updates.
Source: [Investing.com](https://www.investing.com/news/analyst-ratings/jefferies-lowers-procept-biorobotics-price-target-on-procedure-miss-93CH-4837388)
Developing story β details emerging. Check the source link for the latest updates.
Lillyβs sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.